$KULR
KULR Technology Group, Inc.

2017 Q2 Form 10-Q Financial Statement

#000114420417044186 Filed on August 18, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $10.90K $3.600K
YoY Change 202.78%
Cost Of Revenue $56.20K $5.166K
YoY Change 987.79%
Gross Profit -$45.30K -$1.566K
YoY Change 2792.4%
Gross Profit Margin -415.55% -43.5%
Selling, General & Admin $332.4K
YoY Change
% of Gross Profit
Research & Development $36.45K $2.083K
YoY Change 1649.78%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $638.8K $202.4K
YoY Change 215.57%
Operating Profit -$684.1K -$204.0K
YoY Change 235.35%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$6.671K $665.00
YoY Change -1103.16%
Pretax Income -$690.6K -$203.3K
YoY Change 239.63%
Income Tax $200.00 $200.00
% Of Pretax Income
Net Earnings -$690.8K -$203.5K
YoY Change 239.39%
Net Earnings / Revenue -6337.38% -5653.69%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 783.2K shares 4.867M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.210M
YoY Change
Cash & Equivalents $2.213M $9.087K $161.4K
Short-Term Investments
Other Short-Term Assets $8.727K $3.648K
YoY Change
Inventory $12.93K $12.93K
Prepaid Expenses $12.34K
Receivables $10.00K
Other Receivables $0.00
Total Short-Term Assets $2.454M $164.1K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $21.63K $462.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $21.63K $462.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.454M $164.1K
Total Long-Term Assets $21.63K $462.00
Total Assets $2.476M $164.5K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $710.0K $13.49K
YoY Change 259.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $739.5K $431.7K
YoY Change 11411.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $224.0K
YoY Change
Total Long-Term Liabilities $0.00 $224.0K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $739.5K $431.7K
Total Long-Term Liabilities $0.00 $224.0K
Total Liabilities $740.0K $237.5K
YoY Change 6233.17%
SHAREHOLDERS EQUITY
Retained Earnings -$1.934M
YoY Change 47507.34%
Common Stock $1.664M
YoY Change 71876.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.740M -$267.2K
YoY Change
Total Liabilities & Shareholders Equity $2.480M $164.5K
YoY Change

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income -$690.8K -$203.5K
YoY Change 239.39%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change
Cash From Operating Activities $440.0K -$40.00K $110.0K
YoY Change 300.0%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $1.740M $0.00 -$90.00K
YoY Change -2033.33%
Cash From Investing Activities $1.720M $0.00 -$90.00K
YoY Change -2011.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 440.0K -40.00K 110.0K
Cash From Investing Activities 1.720M 0.000 -90.00K
Cash From Financing Activities 0.000
Net Change In Cash 2.160M -40.00K 20.00K
YoY Change 10700.0%
FREE CASH FLOW
Cash From Operating Activities $440.0K -$40.00K $110.0K
Capital Expenditures -$20.00K $0.00 $0.00
Free Cash Flow $460.0K -$40.00K $110.0K
YoY Change 318.18%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Operating Income Loss
OperatingIncomeLoss
-909942 USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Operating Income Loss
OperatingIncomeLoss
-402956 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Entity Registrant Name
EntityRegistrantName
KT High-Tech Marketing Inc.
dei Amendment Flag
AmendmentFlag
false
CY2017Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
77440000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001662684
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Type
DocumentType
10-Q
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
431686 USD
dei Document Period End Date
DocumentPeriodEndDate
2017-06-30
CY2017Q2 us-gaap Liabilities Current
LiabilitiesCurrent
739539 USD
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q2 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
0 USD
CY2016Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
2152 USD
CY2016Q4 us-gaap Notes Receivable Related Parties Current
NotesReceivableRelatedPartiesCurrent
85000 USD
us-gaap Revenues
Revenues
10900 USD
us-gaap Revenues
Revenues
6900 USD
us-gaap Cost Of Revenue
CostOfRevenue
56195 USD
CY2017Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-203533 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-690774 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-683903 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-203998 USD
CY2017Q2 us-gaap Revenues
Revenues
10900 USD
CY2016Q2 us-gaap Revenues
Revenues
3600 USD
CY2017Q2 us-gaap Cost Of Revenue
CostOfRevenue
56195 USD
CY2016Q2 us-gaap Cost Of Revenue
CostOfRevenue
5166 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
-45295 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-1566 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-690574 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-203333 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 USD
us-gaap Net Income Loss
NetIncomeLoss
-402686 USD
us-gaap Net Income Loss
NetIncomeLoss
-918598 USD
us-gaap Cost Of Revenue
CostOfRevenue
7749 USD
us-gaap Gross Profit
GrossProfit
-45295 USD
us-gaap Gross Profit
GrossProfit
-849 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-918198 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-402286 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
281756 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2203972 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
107692 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
22692 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138753 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161445 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
183370 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
20954 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1200354 USD
us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
510378 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-2152 USD
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
652 USD
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
85000 USD
us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
0 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1922216 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-85000 USD
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77440000 shares
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77440000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50000000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50000000 shares
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52570582 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45133471 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
50791128 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43379274 shares
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, together with amounts disclosed in the related notes to the financial statements. The Company&#8217;s significant estimates used in these financial statements include, but are not limited to, stock-based compensation, the collectability of receivables, inventory valuations, the recoverability and useful lives of long-lived assets and the valuation allowance related to the Company&#8217;s deferred tax assets. Certain of the Company&#8217;s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company&#8217;s estimates and could cause actual results to differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
10900 USD
CY2016Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
6900 USD
CY2017Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
0 USD
CY2016Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
30000 USD
CY2017Q2 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
0 USD
CY2016Q4 us-gaap Due From Other Related Parties Current
DueFromOtherRelatedPartiesCurrent
2000 USD
CY2017Q2 us-gaap Inventory Net
InventoryNet
12932 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
12932 USD
CY2017Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8727 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3648 USD
CY2017Q2 us-gaap Assets Current
AssetsCurrent
2454486 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
164063 USD
CY2017Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21625 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
462 USD
CY2017Q2 us-gaap Assets
Assets
2476111 USD
us-gaap Operating Expenses
OperatingExpenses
402107 USD
CY2016Q4 us-gaap Assets
Assets
164525 USD
CY2017Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
263119 USD
CY2016Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
72445 USD
CY2017Q2 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
476420 USD
CY2016Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
359241 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36448 USD
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2083 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49628 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2083 USD
CY2017Q2 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
269942 USD
CY2016Q2 us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
84679 USD
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
401057 USD
us-gaap Other Research And Development Expense
OtherResearchAndDevelopmentExpense
194058 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
332218 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
115670 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
413962 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
205966 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
638608 USD
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
202432 USD
us-gaap Operating Expenses
OperatingExpenses
864647 USD
CY2017Q2 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
603 USD
CY2016Q2 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
652 USD
us-gaap Interest Income Related Party
InterestIncomeRelatedParty
1337 USD
us-gaap Interest Income Related Party
InterestIncomeRelatedParty
652 USD
CY2017Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
7274 USD
CY2016Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
9593 USD
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
0 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6671 USD
CY2016Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
665 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8256 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
670 USD
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
13 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
0 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
18 USD
CY2017Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
99654 USD
CY2017Q2 cik0001662684 Accrued Payroll
AccruedPayroll
54331 USD
CY2016Q4 cik0001662684 Accrued Payroll
AccruedPayroll
0 USD
CY2017Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
46189 USD
CY2017Q2 cik0001662684 Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
29292 USD
CY2017Q2 cik0001662684 Credit Card Payable
CreditCardPayable
25266 USD
CY2017Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8387 USD
CY2017Q2 cik0001662684 Accrued Research And Development Expenses Related Parties
AccruedResearchAndDevelopmentExpensesRelatedParties
476420 USD
CY2016Q4 cik0001662684 Accrued Research And Development Expenses Related Parties
AccruedResearchAndDevelopmentExpensesRelatedParties
351540 USD
CY2017Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2016Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
7701 USD
CY2017Q2 cik0001662684 Accounts Payable And Other Accrued Liabilities Current Related Parties
AccountsPayableAndOtherAccruedLiabilitiesCurrentRelatedParties
476420 USD
CY2016Q4 cik0001662684 Accounts Payable And Other Accrued Liabilities Current Related Parties
AccountsPayableAndOtherAccruedLiabilitiesCurrentRelatedParties
359241 USD
us-gaap Depreciation
Depreciation
882 USD
us-gaap Depreciation
Depreciation
344 USD
us-gaap Share Based Compensation
ShareBasedCompensation
224158 USD
us-gaap Share Based Compensation
ShareBasedCompensation
14949 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-7749 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-861377 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
152476 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
471274 USD
us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
114679 USD
us-gaap Increase Decrease In Due To Other Related Parties Current
IncreaseDecreaseInDueToOtherRelatedPartiesCurrent
41268 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22045 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
85000 USD
us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
0 USD
cik0001662684 Cash Acquired In Reverse Recapitalisation
CashAcquiredInReverseRecapitalisation
1859261 USD
cik0001662684 Cash Acquired In Reverse Recapitalisation
CashAcquiredInReverseRecapitalisation
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3600 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-30000 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 USD
us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
-2000 USD
us-gaap Increase Decrease Due From Other Related Parties
IncreaseDecreaseDueFromOtherRelatedParties
0 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
224158 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2698173 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> Concentrations of Credit Risk</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The Company maintains cash in bank accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts, periodically evaluates the creditworthiness of the financial institutions and has determined the credit exposure to be negligible.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">During the three and six months ended June 30, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font></font>% of the Company&#8217;s revenues were generated from the Customer A. During the three and six months ended June 30, 2017, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font></font>% of the Company&#8217;s revenues were generated from Customer B. As of June 30, 2017, a receivable from Customer B comprised <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the Company&#8217;s total account receivable. As of December 31, 2016, a receivable from Customer A comprised <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 100</font>% of the Company&#8217;s total account receivable.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.6457 pure
CY2017Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
32000 USD
CY2017Q2 cik0001662684 Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
306390 USD
CY2016Q2 cik0001662684 Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
86762 USD
cik0001662684 Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
450685 USD
cik0001662684 Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
196141 USD
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
651869 USD
CY2017Q2 cik0001662684 Employee Service Sharebased Compensation Nonvested Awards Compensation Cost Not Yet Recognized Subject To Remeasurement
EmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedSubjectToRemeasurement
466201 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P10M24D
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
783196 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4866529 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
876496 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6620726 shares
us-gaap Income Taxes Paid
IncomeTaxesPaid
1600 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
us-gaap Interest Paid
InterestPaid
0 USD
CY2017Q2 cik0001662684 Working Capital
WorkingCapital
1714947 USD
us-gaap Interest Paid Net
InterestPaidNet
3488 USD

Files In Submission

Name View Source Status
0001144204-17-044186-index-headers.html Edgar Link pending
0001144204-17-044186-index.html Edgar Link pending
0001144204-17-044186.txt Edgar Link pending
0001144204-17-044186-xbrl.zip Edgar Link pending
cik0001662684-20170630.xml Edgar Link completed
cik0001662684-20170630.xsd Edgar Link pending
cik0001662684-20170630_cal.xml Edgar Link unprocessable
cik0001662684-20170630_def.xml Edgar Link unprocessable
cik0001662684-20170630_lab.xml Edgar Link unprocessable
cik0001662684-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v473389_10q.htm Edgar Link pending
v473389_ex31-1.htm Edgar Link pending
v473389_ex31-2.htm Edgar Link pending
v473389_ex32-1.htm Edgar Link pending
v473389_ex32-2.htm Edgar Link pending
v473389_img1.jpg Edgar Link pending